Zen Technologies Q1 FY27 — Deep Dive: Weak Quarter, Strong Order Book

Key Financial Highlights

Note: Another reported figure of ₹31.85 Cr PAT includes an exceptional loss of ₹3.37 Cr (insurance-covered fire at Unistring subsidiary). Excluding that, normalized PAT is ~₹34.46 Cr.

Management Commentary (from Investor Presentation & Pre-Concall Materials)

The earnings conference call is scheduled for today (27 July 2026), but the investor presentation released on 25 July offers significant color:

On Execution & Revenue Timing

"We entered FY27 with clear visibility on execution" — Management stated that Q1 FY27 revenue was consistent with expectations as the execution of orders secured from October 2025 onward is weighted towards Q2 and Q3 FY27. The typical execution cycle is ~12 months, and revenue recognition follows a back-ended pattern.

Key quote: "We remain on track with our delivery schedules. With a materially broadened product suite and a strong order pipeline, we are well placed to convert the opportunities ahead of us as the year progresses."

On the Order Book

Consolidated order book: ₹1,239.02 Cr as of 30 June 2026, comprising:

• Equipment orders: ₹920.59 Cr
• AMC orders: ₹318.43 Cr

Already in July 2026, the company received an additional ₹177.50 Cr simulator order from Ministry of Defence for upgradation and integration of Tank and Crew Gunnery Simulators.

On Product Portfolio Expansion

Seven new products unveiled including:

1. AI-powered anti-drone system (High-altitude man-portable system launched on Kargil Vijay Diwas)
2. Hyperstrike interceptor drone
3. Zen Vrishab unmanned ground vehicle
4. Integrated Smart Border Suite (India's first AI-powered border surveillance solution)
5. R&D completed for first Air Force training solution
6. OEM partnerships at advanced stage for air simulator segment entry
7. DAC approval for ₹52,000 Cr including AKASH TARANG anti-UAV system

On the Air Simulator Expansion

A critical strategic update: Zen has completed R&D for its first product offering to the Indian Air Force and is in advanced-stage negotiations with OEM partners for entry into the air simulator domain — expected to be formalized during FY27. Currently, the company is the leader in Army and Navy domains; Air Force would complete the trifecta.

On Industry Tailwinds

Management highlighted:

• Government's sustained prioritization of counter-drone systems, layered air defence, and unmanned platforms
• DAC clearances over past months supporting procurement environment
• Continued emphasis on Buy Indian-IDDM (Indigenously Designed, Developed and Manufactured) procurement
• These trends "reinforce the relevance of Zen's portfolio and create opportunities for order conversion"

Key Board Decisions

1. QIP Timeline Extension: The board approved extending the deadline for utilizing unutilized QIP proceeds by 24 months (from August 23, 2026 to August 22, 2028). The funds are earmarked for inorganic growth, acquisitions, and strategic initiatives. No change in the objects of the issue — only the timeline.

2. New Board Appointments:

   • Jasthi Krishna Kishore appointed as Additional Director & Non-Executive Independent Director (3 years from 25 Jul 2026)
   • Shilpa Choudari reappointed as Whole-Time Director for another 3 years from 1 Nov 2026

3. ESOP Activity: 70,000 equity shares purchased through ESOP Trust; 5,850 shares transferred to eligible employees.

Operating Metrics Deep-Dive

Revenue Analysis

The ₹141.64 Cr revenue is the lowest quarterly figure in 7 quarters — below the ₹152-178 Cr range maintained since Dec'24. On a sequential basis, revenue fell 20.5% from Q4 FY26, and the March 2025 quarter had an anomalous ₹324.97 Cr (driven by large-order deliveries in Q4 FY25).

Margin Analysis

Operational EBITDA margin of 27.3% is the weakest in 7 quarters, a far cry from the 38-42% historical range. Causes:

• Employee costs rose to 24.3% of revenue (vs 20.1% a year ago) — talent acquisition for expanded order book
• Other expenses surged 83.9% YoY to ₹30.05 Cr
• The 40.9% EBITDA figure quoted in the investor presentation includes Other Income of ₹19.16 Cr — the operational figure is the 27.3%

Other Income Reliance — Caution Flag

Other Income of ₹19.16 Cr constituted 39.4% of PBT — significantly above the sustainable threshold of 20-25%. While Zen has a strong cash-rich balance sheet, this level of non-operating income dependency is unusual and merits monitoring.

Exceptional Item

An exceptional loss of ₹3.37 Cr was recorded after inventory at subsidiary Unistring Tech Solutions was damaged in a fire on April 25, 2026. The damaged inventory is adequately insured — the insurance survey is pending.

Segment Performance

Balance Sheet & Financial Health

• Debt-free (net cash position, D/E: -0.18)
• Shareholder funds: ₹1,700.69 Cr (as of Mar'25)
• Current assets: ₹1,603.99 Cr vs Current liabilities: ₹243.97 Cr (ample liquidity)
• Negative operating cash flow of ₹146 Cr in FY25, driven by ₹419 Cr working capital build-up (inventory for order execution)
• Finance costs declined 68.5% YoY to ₹1.09 Cr
• Fixed assets more than doubled to ₹183.65 Cr (capacity expansion)

Shareholding Pattern

Institutional holding at 16.88% — increasing participation from mutual funds and FIIs. The company conducted multiple analyst meets in June 2026, suggesting active institutional engagement.

Valuation

Peer Comparison

At 79-83x P/E, Zen trades at a premium to most defence peers except Data Patterns, justified historically by exceptional growth but questioned given recent execution challenges.

Forward PE Considerations

With the FY27 revenue target of ~₹1,500 Cr looking stretched at the current run-rate (Q1 annualized: ~₹566 Cr), valuation is heavily dependent on Q2-Q3 execution acceleration. The order book of ₹1,239 Cr provides ~8 months of coverage at guided revenue levels.

Recent News & Catalysts

🟢 Positive

• ₹177.50 Cr MoD order secured in July 2026 for simulator upgrades
• Seven new products unveiled including AI anti-drone system
• DAC approval for ₹52,000 Cr including anti-UAV systems — large pipeline opportunity
• Arms manufacturing license secured from Indian government (earlier in 2026)

🟡 Neutral

• QIP deadline extended by 24 months (no change in objectives)
• New board appointments strengthening governance

🔴 Concerns

• No new order wins disclosed for Q1 FY27 itself
• Revenue weakest in 7 quarters
• Operating margins compressed to 27.3%
• Other Income dependency at 39.4%
• Fire incident at Unistring subsidiary (insured, but operational disruption)

Key Risks

1. Execution Dependency: Revenue heavily back-ended to Q2-Q3 FY27. Any execution delays in defence contracts could compress the full-year delivery window.

2. Margin Normalization Risk: With employee costs at 24.3% of revenue (vs 20% historically) and other expenses surging, the 35%+ EBITDA margin target may be difficult to achieve in FY27.

3. Valuation at Premium: 79x P/E leaves no room for disappointment — any further execution miss could trigger significant multiple compression.

4. Order Pipeline Conversion: While DAC approvals for ₹52,000 Cr in anti-drone systems is a positive, conversion to firm orders depends on procurement timelines.

5. Working Capital Intensity: The ₹419 Cr working capital build in FY25 signals lumpy cash conversion cycles typical of defence contracts.

Verdict & Levels

Verdict: CAUTION

Zen Technologies Q1 FY27 is a classic "messy quarter, intact story" scenario. The headline numbers are weak, but management's narrative of execution-weighted revenue (Q2-Q3) and the strong ₹1,239 Cr order book (with a further ₹177.50 Cr added in July) provide visibility. The stock is down ~4% today on the results, suggesting the market is pricing in the known weakness.

Key levels to watch:

• Support: ₹1,580 (near 200 DMA zone), ₹1,460 (swing low)
• Resistance: ₹1,770 (pre-result close), ₹1,850 (QIP price zone), ₹2,024 (52W high)

What needs to happen for the bull case to re-assert: Strong Q2 execution (revenue ₹200 Cr+) and margin recovery to 32%+. The Q2 FY27 results in late October will be the true test.